Risultati per: La FDA approva il sistema di riabilitazione dell’ictus

This cohort study assesses the validity of molecular targets and therapeutic benefits of US Food and Drug Administration (FDA)–approved genome-targeted cancer drugs based on the outcomes of their corresponding pivotal clinical trials.

Nei giorni scorsi trovate tracce di virus, ma non è infettivo

In this Viewpoint, the Supreme Court case FDA v AHM is used to illustrate the tension the FDA faces between science and politics, and state authority over abortion vs federal authority over which drugs may be marketed nationwide.

Al via Congresso,test su popolazione insieme alla GdF a L’Aquila

Potra’ essere usato anche dai medici di base Usa

Download solo con prescrizione, non è alternativa ai farmaci

Approval was based on 12-month liver biopsy findings.

Per il mantenimento, è somministrato bimestralmente

The US Food and Drug Administration (FDA) approved omalizumab, marketed as Xolair, to treat various food allergies in people aged 1 year or older. Omalizumab is a monoclonal antibody that blocks immunoglobulin E, a protein that triggers allergic reactions, including severe ones like anaphylaxis. The FDA first approved the drug in 2003 for treating allergic asthma.

The US Food and Drug Administration (FDA) announced it had greenlit the first medication, known as iloprost, to treat severe frostbite. When it’s injected, iloprost, marketed as Aurlumyn, dilates blood vessels and prevents clotting so people with frostbite have a lower risk of needing their fingers or toes amputated. The FDA first authorized the drug for the treatment of pulmonary arterial hypertension in 2004.

Studio Univaq su Journal of Neurology, Neurosurgery, Psychiatry

‘Istituto di Trieste pioniere nell’incentivare donne ai vertici’

Balzanelli, “consistente e determinante il loro impegno”

Sinpia: “Necessario intervento tempestivo neuropsichiatra”

E’ tra le prime cause di morte nel continente. Parte progetto di cooperazione in Congo